ANNX: Annexon, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 703.10
Enterprise Value ($M) 477.99
Book Value ($M) 250.56
Book Value / Share 2.78
Price / Book 2.81
NCAV ($M) 216.74
NCAV / Share 2.41
Price / NCAV 3.24

Profitability (mra)
Return on Invested Capital (ROIC) -0.48
Return on Assets (ROA) -0.47
Return on Equity (ROE) -0.58

Liquidity (mrq)
Quick Ratio 14.72
Current Ratio 14.72

Balance Sheet (mrq) ($M)
Current Assets 263.86
Assets 297.67
Liabilities 47.12
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -143.72
Net Income -134.24

Cash Flow Statement (mra) ($M)
Cash From Operations -121.14
Cash from Investing 70.70
Cash from Financing 135.52

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Eventide Asset Management, Llc 0.00 -100.00
02-14 13G/A Venrock Healthcare Capital Partners II, L.P. 1.20 -80.35
02-14 13G/A Fairmount Funds Management LLC 0.40 -91.23
02-14 13G/A Redmile Group, LLC 9.90 65.06
02-14 13G/A Citadel Advisors Llc 1.40
02-14 13G/A Biotechnology Value Fund L P 8.90 85.15
02-13 13G/A Bain Capital Life Sciences Fund, L.P. 9.99 174.15
02-13 13G/A Logos Global Management LP 8.30 124.01
02-12 13G Point72 Asset Management, L.P. 6.20
02-07 13G/A Adage Capital Partners Gp, L.l.c. 7.15 34.56
01-10 13G Fmr Llc 12.37 622.78
08-08 13G/A Federated Hermes, Inc. 4.41 -23.39

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 410,054 2,915,126 14.07
2024-03-27 714,693 5,318,897 13.44
2024-03-26 241,435 1,652,467 14.61
2024-03-25 210,823 1,698,390 12.41

(click for more detail)

Similar Companies
AMPH – Amphastar Pharmaceuticals, Inc. AMRX – Amneal Pharmaceuticals, Inc.
ANAB – AnaptysBio, Inc. APLS – Apellis Pharmaceuticals, Inc.
ARQT – Arcutis Biotherapeutics, Inc.


Financial data and stock pages provided by
Fintel.io